z-logo
open-access-imgOpen Access
Letter by Gronda et al Regarding Article, “Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial”
Author(s) -
Edoardo Gronda,
Furio Colivicchi,
Giuseppe Zuccalà
Publication year - 2022
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.121.057530
Subject(s) - empagliflozin , medicine , ejection fraction , heart failure , emperor , heart failure with preserved ejection fraction , cardiology , ancient history , endocrinology , diabetes mellitus , type 2 diabetes mellitus , history

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom